Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Trade Secrets Case Watch
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • Health Care Counsel Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Search

Breadcrumb

  1. Services
  2. Pharmaceuticals & Medical Devices

Insights on Pharmaceuticals & Medical Devices

164 total results. Page 7 of 7.

Health Care Counsel Blog
Long-Awaited 340B Program Guidance Now Available for Comments: What Stakeholders Need to Know
September 10, 2015
Stephanie Trunk

The Health Resources and Services Administration, as administrator of the 340B Drug Pricing Program on behalf of the Department of Health and Human Services (HHS), published its proposed 340B Drug Pricing Program Omnibus Guidance on August 28, 2015.

Health Care Counsel Blog
OIG Issues Favorable Advisory Opinion to Pharmaceutical Manufacturer Related to a Free Starter or Bridge Program
August 17, 2015
Stephanie Trunk

On August 5, 2015, the Department of Health and Human Services Office of Inspector General (OIG) issued Advisory Opinion No. 15-11.

Alerts
US District Court Affirms First Amendment Protection of Off-Label Drug Promotion
August 17, 2015
Wayne H. Matelski, Emily Cowley Leongini

On August 7, 2015, the US District Court for the Southern District of New York issued a significant decision concerning FDA’s regulation of off-label promotion of approved drugs.

Health Care Counsel Blog
HRSA Proposed Rule on Calculating the 340B Ceiling Price and Penalties Related to 340B Drug Discount Program
June 18, 2015
Stephanie Trunk

On June 17, 2015, the Health Resources and Services Administration (HRSA) published a long-awaited proposed rule setting forth revisions to the current regulations governing the 340B Drug Discount Program (340B Program) as set forth in 42 C.F.R. part 10 (Proposed Rule).

Health Care Counsel Blog
Unsealed False Claims Act Suit Asserts that Reverse Payment Settlements Create Government Overpayments
May 22, 2015
Brian D. Schneider, D. Jacques Smith, Randall A. Brater, Stephanie Trunk

Pharmaceutical manufacturers could face a new line of attack related to Hatch-Waxman reverse payment settlement agreements (so-called, “pay-for-delay” settlements).

Health Care Counsel Blog
Medicaid Drug Rebate Program (MDRP) Summit
Stephanie Trunk

Health Care Co-Leader Stephanie Trunk will present at Informa’s Medicaid Drug Rebate Program Summit.

Events
American Health Lawyers Association (AHLA) 2019 Annual Meeting
Stephanie Trunk

Health Care Co-Leader Stephanie Trunk and Health Care Partner Rachel Hold-Weiss will present at AHLA’s 2019 Annual Meeting.

Events
CBI’s 21st Annual Medicaid and Government Pricing Congress
Stephanie Trunk

Health Care Co-Leader Stephanie Trunk will present at CBI’s 21st Annual Medicaid and Government Pricing Congress.

Events
HDA’s 2019 Distribution Management Conference and Expo
Stephanie Trunk

Health Care Co-Leader Stephanie Trunk will present at the Healthcare Distribution Alliance’s 2019 Distribution Management Conference and Expo.

Events
CBI’s 4th Drug Pricing Transparency Congress
Stephanie Trunk

Health Care Co-Leader Stephanie Trunk will present at CBI’s 4th Drug Pricing Transparency Congress.

Events
#MDRP18: Medicaid Drug Rebate Program
Stephanie Trunk

Health Care Partner Stephanie Trunk will present at the Medicaid Drug Rebate Program.

Events
GRx+Biosims: Engineering the Future of Generic & Biosimilar Medicines
Stephanie Trunk

Health Care Partner Stephanie Trunk will present at the GRx+Biosims Conference on the “Drug Pricing and Update on State Legal Issues” panel.

Events
Mastering Opioid Law & Regulation
Douglas A. Grimm

Health Care Partner Douglas Grimm will speak at The Rossdale Group’s CLE webinar entitled “Mastering Opioid Law & Regulation.”

Events
GPO Membership Eligibility and Class of Trade Maintenance Forum
Stephanie Trunk

Health care Partner Stephanie Trunk will speak at CBI’s 4th Annual GPO Membership Eligibility and Class of Trade Maintenance Forum.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2026 ArentFox Schiff LLP. All Rights Reserved.

Back to Top